CBD may hold promise as a tool to help people reduce problem drinking, according to a new study published in Alcohol: Clinical and Experimental Research. Cannabidiol, commonly known as CBD, modifies the activity of the parasympathetic nervous system and reduces physical signs of anxiety and self-reported craving for alcohol in people with alcohol use disorder.
Tag: cannabidiol
CBD oil doesn’t reduce pain after common treatment for urinary stones
Treatment with an FDA-approved cannabidiol (CBD) oil product does not lower pain scores after surgical treatment and stent placement for patients with urinary stones, reports a clinical trial in the April issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Vaping CBD can increase susceptibility to respiratory infection, says Roswell Park study author
Dr. Thanavala is available for virtual or in-person interviews Monday, Feb. 27 or Tuesday, Feb 28. Press release: https://www.roswellpark.org/newsroom/202302-vaping-cbd-causes-more-severe-lung-damage-vaping-nicotine-roswell-park-study-shows Link to her bio here. Dr. Thanavala has been at the forefront of research on the health effects of vaping cannabinoids.…
Vaping CBD Causes More Severe Lung Damage Than Vaping Nicotine, Roswell Park Study Shows
Vaping cannabidiol (CBD), a compound found in marijuana, leads to more severe lung damage than vaping nicotine, according to a study out of Roswell Park Comprehensive Cancer Center. Until now, research on the health effects of vaping, or using e-cigarettes, has focused almost exclusively on vaping nicotine as opposed to CBD. Previous research has documented the effects of smoking cannabis, but the effects of vaping cannabinoids such as CBD were not previously known.
CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows
Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a “high” sensation. The findings show that in edible cannabis products, CBD inhibits the metabolism, or breakdown, of THC, which may result in stronger and longer drug effects.
Cannabis has same effect on adolescents and adults, and CBD doesn’t dampen effects
The short-term effects of vaporised cannabis do not differ between adolescents and adults, while cannabidiol (CBD) does not dampen the effects of the drug, finds a new study led by UCL and King’s College London researchers.
New Gastroparesis Clinical Guideline Featured in August Issue of AJG
The August issue of The American Journal of Gastroenterology highlights new clinical science, including a brand new ACG clinical guideline for the diagnosis and treatment of patients with gastroparesis.
Buccally Absorbed Cannabidiol is Safe and Effective for Pain Management After Rotator Cuff Surgery
Cannabidiol is effective in improving immediate post-operative pain following arthroscopic rotator cuff repair, according to research presented today at the American Orthopaedic Society of Sports Medicine 2022 Annual Meeting.
Very high doses of CBD, a cannabis component, don’t affect driving
Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving. The University of Sydney-led research finds that 1500mg, the highest daily medicinal dose of cannabidiol (CBD), has no impact on people’s driving or cognitive abilities.
Spontaneous Mammary Neoplasia, Cannabidiol Exposure, Aryl Hydrocarbon Receptors, and More Featured in July 2021 Toxicological Sciences
Toxicological Sciences delivers the latest toxicology research in the July 2021 issue. The issue features investigations in delivers the latest toxicology research in areas such as exposure to delta-9-tetrahydrocannabinol and cannabidiol, effects of ENDS vapors on amino acid metabolism, and more.
Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows
A landmark study on how cannabis affects driving ability has shown that cannabidiol (CBD), a cannabis component now widely used for medical purposes, does not impair driving, while moderate amounts of the main intoxicating component tetrahydrocannabinol (THC) produce mild driving impairment lasting up to four hours.
Current Clinical Trial Assessing Potential of CBD in Treatment of Autism
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
From bench to beach: Award-winning epilepsy researcher furthers understanding of how cannabidiol stops seizures
Lyndsey Anderson traveled halfway around the world to do epilepsy research in Sydney, Australia. Recently, she was awarded ILAE’s 2020 Epilepsia Prize for Basic Science Research.
Compte-rendu de Mayo Clinic : le CBD, l’huile de chanvre pourraient être utiles mais des recherches supplémentaires sont nécessaires
Les huiles de cannabidiol (CBD) et leurs produits dérivés sont devenus de plus en plus populaires auprès des consommateurs, qui peuvent ainsi soulager leurs douleurs, l’anxiété, les troubles du sommeil et d’autres problèmes chroniques. Mais ces produits sont-ils sans danger et sont-ils utiles ?